369 related articles for article (PubMed ID: 11847170)
1. Genetic polymorphisms in the renin-angiotensin-aldosterone system associated with expression of left ventricular hypertrophy in hypertrophic cardiomyopathy: a study of five polymorphic genes in a family with a disease causing mutation in the myosin binding protein C gene.
Ortlepp JR; Vosberg HP; Reith S; Ohme F; Mahon NG; Schröder D; Klues HG; Hanrath P; McKenna WJ
Heart; 2002 Mar; 87(3):270-5. PubMed ID: 11847170
[TBL] [Abstract][Full Text] [Related]
2. Gene-specific modifying effects of pro-LVH polymorphisms involving the renin-angiotensin-aldosterone system among 389 unrelated patients with hypertrophic cardiomyopathy.
Perkins MJ; Van Driest SL; Ellsworth EG; Will ML; Gersh BJ; Ommen SR; Ackerman MJ
Eur Heart J; 2005 Nov; 26(22):2457-62. PubMed ID: 16087648
[TBL] [Abstract][Full Text] [Related]
3. RAAS gene polymorphisms influence progression of pediatric hypertrophic cardiomyopathy.
Kaufman BD; Auerbach S; Reddy S; Manlhiot C; Deng L; Prakash A; Printz BF; Gruber D; Papavassiliou DP; Hsu DT; Sehnert AJ; Chung WK; Mital S
Hum Genet; 2007 Dec; 122(5):515-23. PubMed ID: 17851694
[TBL] [Abstract][Full Text] [Related]
4. The role of renin-angiotensin-aldosterone system polymorphisms in phenotypic expression of MYBPC3-related hypertrophic cardiomyopathy.
Kolder IC; Michels M; Christiaans I; Ten Cate FJ; Majoor-Krakauer D; Danser AH; Lekanne Deprez RH; Tanck M; Wilde AA; Bezzina CR; Dooijes D
Eur J Hum Genet; 2012 Oct; 20(10):1071-7. PubMed ID: 22569109
[TBL] [Abstract][Full Text] [Related]
5. Myocardial fibrosis in patients with symptomatic obstructive hypertrophic cardiomyopathy: correlation with echocardiographic measurements, sarcomeric genotypes, and pro-left ventricular hypertrophy polymorphisms involving the renin-angiotensin-aldosterone system.
Blauwet LA; Ackerman MJ; Edwards WD; Riehle DL; Ommen SR
Cardiovasc Pathol; 2009; 18(5):262-8. PubMed ID: 18835191
[TBL] [Abstract][Full Text] [Related]
6. Impact of polymorphisms in the renin-angiotensin-aldosterone system on hypertrophic cardiomyopathy.
Orenes-Piñero E; Hernández-Romero D; Jover E; Valdés M; Lip GY; Marín F
J Renin Angiotensin Aldosterone Syst; 2011 Dec; 12(4):521-30. PubMed ID: 21507890
[TBL] [Abstract][Full Text] [Related]
7. Development of left ventricular hypertrophy in adults in hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations.
Maron BJ; Niimura H; Casey SA; Soper MK; Wright GB; Seidman JG; Seidman CE
J Am Coll Cardiol; 2001 Aug; 38(2):315-21. PubMed ID: 11499718
[TBL] [Abstract][Full Text] [Related]
8. Diastolic abnormalities as the first feature of hypertrophic cardiomyopathy in Dutch myosin-binding protein C founder mutations.
Michels M; Soliman OI; Kofflard MJ; Hoedemaekers YM; Dooijes D; Majoor-Krakauer D; ten Cate FJ
JACC Cardiovasc Imaging; 2009 Jan; 2(1):58-64. PubMed ID: 19356534
[TBL] [Abstract][Full Text] [Related]
9. Hypertrophic cardiomyopathy in myosin-binding protein C (
Adalsteinsdottir B; Burke M; Maron BJ; Danielsen R; Lopez B; Diez J; Jarolim P; Seidman J; Seidman CE; Ho CY; Gunnarsson GT
Open Heart; 2020; 7(1):e001220. PubMed ID: 32341788
[TBL] [Abstract][Full Text] [Related]
10. Lack of association among five genetic polymorphisms of the renin-angiotensin system and cardiac hypertrophy in patients with aortic stenosis.
Ortlepp JR; Breithardt O; Ohme F; Hanrath P; Hoffmann R
Am Heart J; 2001 Apr; 141(4):671-6. PubMed ID: 11275936
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic differences between electrocardiographic and echocardiographic determination of hypertrophic cardiomyopathy in genetically affected subjects.
Konno T; Shimizu M; Ino H; Fujino N; Hayashi K; Uchiyama K; Kaneda T; Inoue M; Masuda E; Mabuchi H
J Intern Med; 2005 Sep; 258(3):216-24. PubMed ID: 16115294
[TBL] [Abstract][Full Text] [Related]
12. Association of renin-angiotensin-aldosterone system gene polymorphisms with left ventricular hypertrophy in patients with heart failure with preserved ejection fraction: A case-control study.
Bahramali E; Firouzabadi N; Rajabi M; Manafi A; Zarghami M; Mousavi SM; Jamshidi J
Clin Exp Hypertens; 2017; 39(4):371-376. PubMed ID: 28513230
[TBL] [Abstract][Full Text] [Related]
13. Role of candidate modifier genes on the phenotypic expression of hypertrophy in patients with hypertrophic cardiomyopathy.
Brugada R; Kelsey W; Lechin M; Zhao G; Yu QT; Zoghbi W; Quinones M; Elstein E; Omran A; Rakowski H; Wigle D; Liew CC; Sole M; Roberts R; Marian AJ
J Investig Med; 1997 Dec; 45(9):542-51. PubMed ID: 9444881
[TBL] [Abstract][Full Text] [Related]
14. Genetic variation in angiotensin II type 2 receptor gene influences extent of left ventricular hypertrophy in hypertrophic cardiomyopathy independent of blood pressure.
Carstens N; van der Merwe L; Revera M; Heradien M; Goosen A; Brink PA; Moolman-Smook JC
J Renin Angiotensin Aldosterone Syst; 2011 Sep; 12(3):274-80. PubMed ID: 21163866
[TBL] [Abstract][Full Text] [Related]
15. A novel mutation in the cardiac myosin-binding protein C gene is responsible for hypertrophic cardiomyopathy with severe ventricular hypertrophy and sudden death.
Konno T; Shimizu M; Ino H; Fujino N; Uchiyama K; Mabuchi T; Sakata K; Kaneda T; Fujita T; Masuta E; Mabuchi H
Clin Sci (Lond); 2006 Jan; 110(1):125-31. PubMed ID: 16181148
[TBL] [Abstract][Full Text] [Related]
16. AT1 receptor A/C1166 polymorphism contributes to cardiac hypertrophy in subjects with hypertrophic cardiomyopathy.
Osterop AP; Kofflard MJ; Sandkuijl LA; ten Cate FJ; Krams R; Schalekamp MA; Danser AH
Hypertension; 1998 Nov; 32(5):825-30. PubMed ID: 9822439
[TBL] [Abstract][Full Text] [Related]
17. Novel deletions in MYH7 and MYBPC3 identified in Indian families with familial hypertrophic cardiomyopathy.
Waldmüller S; Sakthivel S; Saadi AV; Selignow C; Rakesh PG; Golubenko M; Joseph PK; Padmakumar R; Richard P; Schwartz K; Tharakan JM; Rajamanickam C; Vosberg HP
J Mol Cell Cardiol; 2003 Jun; 35(6):623-36. PubMed ID: 12788380
[TBL] [Abstract][Full Text] [Related]
18. The influence of the angiotensin I converting enzyme genotype in familial hypertrophic cardiomyopathy varies with the disease gene mutation.
Tesson F; Dufour C; Moolman JC; Carrier L; al-Mahdawi S; Chojnowska L; Dubourg O; Soubrier E; Brink P; Komajda M; Guicheney P; Schwartz K; Feingold J
J Mol Cell Cardiol; 1997 Feb; 29(2):831-8. PubMed ID: 9140839
[TBL] [Abstract][Full Text] [Related]
19. Myocardial Perfusion Defects in Hypertrophic Cardiomyopathy Mutation Carriers.
Hughes RK; Camaioni C; Augusto JB; Knott K; Quinn E; Captur G; Seraphim A; Joy G; Syrris P; Elliott PM; Mohiddin S; Kellman P; Xue H; Lopes LR; Moon JC
J Am Heart Assoc; 2021 Aug; 10(15):e020227. PubMed ID: 34310159
[TBL] [Abstract][Full Text] [Related]
20. Diastolic dysfunction without left ventricular hypertrophy is an early finding in children with hypertrophic cardiomyopathy-causing mutations in the beta-myosin heavy chain, alpha-tropomyosin, and myosin-binding protein C genes.
Poutanen T; Tikanoja T; Jääskeläinen P; Jokinen E; Silvast A; Laakso M; Kuusisto J
Am Heart J; 2006 Mar; 151(3):725.e1-725.e9. PubMed ID: 16504640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
